Clean ClAImsFirst Pass

CodaMetrix vs Maverick AI

Two Autonomous Medical Coding vendors, side by side. Facts from public sources; judgments are ours.

At a glance

Derived from public facts · a rough scale, not a ranking

CodaMetrixMaverick AI
Pricing model

Not published · Enterprise quotes only

Not published · custom, tied to coding volume

Speed to go live

Four-plus months including silent learning phase

customers typically live within 90 days

Automation model

Autonomous agents · autonomous coding with exception review

Autonomous agents · direct-to-bill autonomous coding

Built for

Enterprise systems

Mid-size groups, Enterprise systems, Billing companies

Security posture

SOC 2 Type II, ISO 27001, HIPAA

HIPAA

Company maturity

7 yrs (est. 2019)

7 yrs (est. 2019)

Financial backing

$110M+ · Series B

$11.5M (per PitchBook) · Seed plus strategic investment

Named customers

5 named

1 named

Published results

No public numbers

Specific numbers public

Documented integrations

1 listed

1 listed

Third-party validation

None found

None found

Bottom line

  • Pick CodaMetrix if you are a large academic or multi-specialty health system ready to fund a months-long project to automate coding at scale.
  • Pick Maverick AI if you want charts coded and sent to billing without human coders, with 85 percent direct-to-bill.

CodaMetrix

Autonomous coding spun out of Mass General Brigham

Founded
2019
HQ
Boston, MA
Stage
Series B
Raised
$110M+

What it does

  • Autonomous coding of professional-fee charges from clinical notes
  • Covers radiology, pathology, surgery, and other specialties
  • Routes low-confidence cases to human coders
  • Clinically enriches claims data for audit and compliance
  • Customers report 60% coding cost and 70% denial reductions

Where it's strong

  • Spun out of Mass General Brigham's own billing operation, so the product was proven on real academic-center volume before it was sold.
  • Reference customers are elite academic systems (MGB, Mount Sinai, Yale, Henry Ford) with published outcome figures.
  • Confidence-based routing to human coders is an honest architecture: it automates what it can prove, not everything.

What buyers should weigh

  • Value scales with volume; it is built for large Epic-based health systems, not small physician groups.
  • Coverage is by specialty and service line, so confirm your highest-volume departments are actually supported.
  • At roughly $110M raised it is well capitalized for its niche but much smaller than the RCM incumbents it displaces.

Named customers

Mass General Brigham · Mount Sinai Health System · Yale Medicine · Henry Ford Health · University of Colorado Medicine

Integrations

Epic (available in Epic Toolbox)
Full CodaMetrix profile →

Maverick AI

Real-time autonomous medical coding for revenue cycle teams

Founded
2019
HQ
n/a
Stage
Seed plus strategic investment
Raised
$11.5M (per PitchBook)

What it does

  • Real-time autonomous coding via the mCoder platform
  • 85%+ direct-to-bill rate without human touch
  • Codes most cases in seconds
  • Reported 95% coding accuracy
  • Streams coded results straight to billing systems

Where it's strong

  • Real-time coding with a published 85%+ direct-to-bill rate, ahead of the batch processing common in the category.
  • Proven at national scale through the RadNet implementation across US imaging sites.
  • The Infinx investment and partnership give it a distribution channel into established RCM operations.

What buyers should weigh

  • Widely cited reports of a $47M 2025 raise belong to competitor Nym, not Maverick; Maverick's disclosed funding is about $11.5M, so weigh vendor financial durability.
  • Public proof points are concentrated in radiology; ask for evidence in other specialties.
  • Roughly 15% of cases still route to human coders, so plan for a review workflow.

Named customers

RadNet

Integrations

Infinx RCM platform
Full Maverick AI profile →

Compare against the rest of Autonomous Medical Coding

Deciding between these two?

First Pass tracks Autonomous Medical Coding every week: funding, launches, and what changed since this page was written.